The semaglutide tablet
No mentions found
This entity hasn't been tracked yet, or Iris is still building its knowledge base.
Related Articles from SNS
First daily pill for weight loss approved by medicines regulator
First daily pill for weight loss approved by medicines regulator The Wegovy semaglutide tablet is taken daily and those with a BMI of 30 or above are eligible - Bookmark - CommentsGo to comments The UK’s first GLP-1 pill for weight loss has been approved by the medicines regulator. The semaglutide tablet, under the brand name Wegovy, is taken daily and obese adults with a body mass index (BMI) of 30 or above qualify.
Breakthrough as UK's first weight loss tablet Wegovy is given green light for use
Breakthrough as UK's first weight loss tablet Wegovy is given green light for use A new prescription-only weight loss tablet has been approved for use in the UK for people who are overweight and have a related condition like high blood pressure The UK's first GLP-1 weight loss pill has been given the green light by the medicines regulator. The Wegovy (semaglutide) tablet, which is taken daily, is for obese adults with a body mass index (BMI) of 30 or above. Those who are overweight and...
UK approves first weight loss pill as GLP-1 tablet gets green light from MHRA
People who've been managing their weight with weekly injections might soon have a far more convenient option. The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has today, 11 June 2026, approved the first GLP-1 receptor agonist tablet for weight loss and weight management in the country. The drug is semaglutide — sold under the brand name Wegovy — and this time it comes in pill form, not a needle.